Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Basic Medical Sciences, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, PR China.
Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, School of Basic Medical Sciences, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, PR China.
Pharmacol Ther. 2017 Jul;175:116-132. doi: 10.1016/j.pharmthera.2017.02.039. Epub 2017 Feb 20.
The neurotransmitter histamine receives less attention compared with other biogenic amines, because of its moderate action in the central nervous system (CNS). However, recent evidence suggests that histamine plays an important role in multiple CNS disorders including insomnia, narcolepsy, Parkinson's diseases, schizophrenia, Alzheimer's disease, and cerebral ischemia. New insights are emerging into the potential roles of histamine receptors as targets for the treatment of these diseases. Although some histamine related agents have failed in clinical trials, current preclinical studies suggest that this neurotransmitter may still have extensive applications in treating CNS disorders, however, advanced studies are warranted. This review summarizes findings from animal models and clinical research on the role of histamine and its receptor ligands in the brain for treatment of CNS disorders. The development of novel histamine receptor ligands and gaining an in-depth understanding of their potential mechanisms are necessary stepping stones to unlock their wide-ranging applications in the clinical arena.
与其他生物胺相比,神经递质组胺由于其在中枢神经系统(CNS)中的中等作用而受到较少关注。然而,最近的证据表明,组胺在多种 CNS 疾病中发挥重要作用,包括失眠、嗜睡症、帕金森病、精神分裂症、阿尔茨海默病和脑缺血。人们对组胺受体作为这些疾病治疗靶点的潜在作用有了新的认识。尽管一些与组胺相关的药物在临床试验中失败,但目前的临床前研究表明,这种神经递质在治疗 CNS 疾病方面仍有广泛的应用,然而,还需要进一步的研究。本综述总结了关于组胺及其受体配体在大脑中治疗 CNS 疾病的作用的动物模型和临床研究结果。开发新型组胺受体配体并深入了解其潜在机制是解锁其在临床领域广泛应用的必要步骤。